TOPIC: To estimate the prevalence of nonrefractive visual impairment and blindness in European persons 55 years of age and older. CLINICAL RELEVANCE: Few visual impairment and blindness prevalence estimates are available for the European population. In addition, many of the data collected in European population-based studies currently are unpublished and have not been included in previous estimates. METHODS: Fourteen European population-based studies participating in the European Eye Epidemiology Consortium (n = 70 723) were included. Each study provided nonrefractive visual impairment and blindness prevalence estimates stratified by age (10-year strata) and gender. Nonrefractive visual impairment and blindness were defined as best-correcte...
PURPOSE: To determine the prevalence of visual impairment (VI) in populations 65 year or older from ...
OBJECTIVE: To estimate the prevalence of age-related maculopathy in an older population from 7 Europ...
Manuscript no. 2016-1147 Supplemental material is available at www.aaojournal.org/International audi...
TOPIC To estimate the prevalence of nonrefractive visual impairment and blindness in European per...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
Authors are on the European Eye Epidemiology (E3) Consortium. Presented at: Association for Research...
PURPOSE: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
The objective of this work was to study the epidemiology of major eye diseases leading to blindness ...
Purpose: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
Purpose: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
textabstractObjective: To estimate the prevalence of age-related maculopathy in an older population ...
Purpose: age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
Purpose: To determine the prevalence of visual impairment (VI) in populations 65 year or older from ...
PURPOSE: To determine the prevalence of visual impairment (VI) in populations 65 year or older from ...
OBJECTIVE: To estimate the prevalence of age-related maculopathy in an older population from 7 Europ...
Manuscript no. 2016-1147 Supplemental material is available at www.aaojournal.org/International audi...
TOPIC To estimate the prevalence of nonrefractive visual impairment and blindness in European per...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
Authors are on the European Eye Epidemiology (E3) Consortium. Presented at: Association for Research...
PURPOSE: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
The objective of this work was to study the epidemiology of major eye diseases leading to blindness ...
Purpose: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
Purpose: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
textabstractObjective: To estimate the prevalence of age-related maculopathy in an older population ...
Purpose: age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
Purpose: To determine the prevalence of visual impairment (VI) in populations 65 year or older from ...
PURPOSE: To determine the prevalence of visual impairment (VI) in populations 65 year or older from ...
OBJECTIVE: To estimate the prevalence of age-related maculopathy in an older population from 7 Europ...
Manuscript no. 2016-1147 Supplemental material is available at www.aaojournal.org/International audi...